Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00500123 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study

Study acronym: ACT
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv21
  2. Site contact updatedv20
  3. Re-verified, no change to tracked fieldsv19
  4. Eligibility criteria expanded, about 19 words
    • Study title expanded, about 8 words
    • Collaborators shortened, about 5 words
    v18
  5. Lead sponsor: Medical University of South Carolina to University of Florida
    • Study site revised
    • Collaborator revised
    v17
Show 15 earlier versionsHide 15 earlier versions
  1. Trial status: Active, Not Recruiting to Recruiting
    • Site details revised
    v16
  2. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v15
  3. 5 versions Re-verified since Apr 17, 2015, no change to tracked fieldsv10-v14
  4. Publications: 4 to 7v9
  5. Re-verified, no change to tracked fieldsv8
  6. Phase: Not applicable to Not specifiedv7 Show 6 more changesShow less
    • Enrollment target: 25000 to 50000
    • Eligibility criteria expanded, about 12 words
    • Study description expanded, about 9 words
    • Publications: 3 to 4
    • Collaborators expanded, about 3 words
    • Study title shortened, about 2 words
  7. 3 versions Re-verified since Feb 12, 2009, no change to tracked fieldsv4-v6
  8. Primary completion date: Jan 2050v3
  9. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The Alpha-1 Coded Testing (ACT) Study was established to study genetic testing and outcomes of individuals at risk for alpha-1 antitrypsin deficiency.
Trial Details
NCT Number NCT00500123
Lead Sponsor University of Florida
Conditions
(from sponsor)		 Alpha-1 Antitrypsin Deficiency
Related terms alpha 1-Antitrypsin Deficiency
Enrollment 50,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov